Doctor Praveen Chandra

Gurgaon (India)

Follow

Contributor content

Quantitative angiographic analysis in patients with de novo native coronary artery lesions treated with novel poly-l-lactide based sirolimus-eluting bioresorbable vascular scaffold: MeRes-1 Trial

Presentation

Quantitative angiographic analysis in patients with de novo native coronary artery lesions treated with novel poly-l-lactide based sirolimus-eluting bioresorbable vascular scaffold: MeRes-1 Trial

ESC 365 is supported by

novartis

Explore sponsored resources